LncRNA regulation of Type I IFN signaling in intestinal epithelium
LncRNA 对肠上皮 I 型 IFN 信号传导的调节
基本信息
- 批准号:10321685
- 负责人:
- 金额:$ 19.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-23 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnti-Inflammatory AgentsBiochemicalBiochemistryBiological Response ModifiersBiologyCell physiologyCellsCellular biologyCommunicationCoupledCryptosporidium parvumDNADataDevelopmentEffector CellEpithelialEpithelial CellsFamilyFeedbackFoundationsFunctional disorderFutureGastrointestinal PhysiologyGastrointestinal tract structureGenesGenetic TranscriptionGoalsHealthHomeostasisHost DefenseHumanImmuneImmune responseImmunityIn VitroInfectionInflammatoryInflammatory ResponseInjuryInterferon Type IInterferon-alphaInterferonsInvestigationLigationMediatingModelingMolecularMolecular ImmunologyMolecular VirologyMorphologyMucosal ImmunityMucous MembraneMusNatural ImmunityOrthologous GeneOutcomeParasitesPathogenicityPlayProductionProteinsRNARegulationResearchRoleSeriesSignal PathwaySignal TransductionSiteSurfaceTranscriptUntranslated RNAadaptive immune responseantimicrobialautocrinechemokinecytokineexperiencegastrointestinalgastrointestinal epitheliumimmunopathologyimmunoreactionin vivoinsightintestinal epitheliumintestinal homeostasismicrobialnovelnovel therapeutic interventionpathogenreceptorresponse
项目摘要
Summary
Epithelial cells along the mucosal surface provide the front line of host defense against pathogen infection in
the gastrointestinal (GI) tract. These epithelial cells represent an integral component of a highly regulated
communication network that can transmit essential signals to cells in the underlying GI mucosa that, in turn,
serve as targets of mucosal immune mediators. How intestinal epithelial cells orchestrate GI mucosal
defense is still not fully understood. LncRNAs are recently identified long non-coding transcripts that can
regulate gene transcription through their interactions with other effect molecules. We have recently identified
a panel of lncRNAs that are upregulated in GI epithelial cells following microbial challenge. Specific lncRNAs
display a significant suppressive effect on Type I interferon (IFN)-controlled gene transcription in GI epithelial
cells. Interestingly, induction of some lncRNAs is controlled by Type I IFN signaling. Given the emerging
significance of lncRNAs in regulation of both innate and adaptive immune responses, coupled with the key
role of Type I IFN signaling in regulating GI homeostasis, we speculate that lncRNAs may be important
regulators in GI physiology and pathophysiology. In this study, we hypothesize that lncRNAs provide
negative feedback regulation of Type I IFN signaling through suppression of Type I IFN-controlled gene
transcription, consequently contributing to fine-tuning of epithelial cell innate defense against microbial
infection. We will use in vitro, ex vivo and in vivo infection models and complementary biochemical,
molecular, and morphologic approaches to elucidate the molecular mechanisms by which lncRNAs modulate
Type I IFN-mediated gene transcription in GI epithelial cells (Aim 1) and determine the role of lncRNA-
mediated feedback regulation of Type I IFN-mediated gene transcription in GI epithelial innate defense (Aim
2). Therefore, this application will explore a novel mechanism for lncRNAs in regulating GI mucosal innate
immunity. Elucidating the regulation of key signal pathways in GI epithelial cells by lncRNAs may reveal new
insights into the molecular immunology and immunopathology of the GI tract.
总结
沿着粘膜表面的上皮细胞提供宿主防御病原体感染的前线,
胃肠道(GI)。这些上皮细胞代表了一个高度调节的
通信网络,可以将基本信号传输到下面的GI粘膜中的细胞,反过来,
作为粘膜免疫介质的靶点。肠上皮细胞如何协调GI粘膜
防御还没有完全理解。lncRNA是最近鉴定的长非编码转录物,
通过与其他效应分子的相互作用来调节基因转录。我们最近发现
一组在微生物攻击后在GI上皮细胞中上调的lncRNA。特异性lncRNA
对GI上皮中I型干扰素(IFN)控制的基因转录显示出显著的抑制作用
细胞有趣的是,一些lncRNA的诱导受I型IFN信号传导控制。鉴于新兴的
lncRNA在调节先天性和适应性免疫应答中的重要性,
I型干扰素信号在调节胃肠道稳态中的作用,我们推测lncRNAs可能是重要的
胃肠道生理学和病理生理学中的调节剂。在这项研究中,我们假设lncRNA提供了
通过抑制I型IFN控制基因的负反馈调节I型IFN信号传导
转录,因此有助于微调上皮细胞对微生物的先天防御
感染我们将使用体外,离体和体内感染模型和互补的生化,
分子和形态学方法来阐明lncRNA调节的分子机制,
胃肠道上皮细胞中I型干扰素介导的基因转录(目的1)并确定lncRNA-的作用
I型IFN介导的基因转录在GI上皮先天防御中的反馈调节(目的
2)的情况。因此,本申请将探索lncRNA在调节GI粘膜先天性免疫应答中的新机制。
免疫力阐明lncRNA对GI上皮细胞中关键信号通路的调节可能揭示新的
深入了解胃肠道的分子免疫学和免疫病理学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xian-Ming Chen其他文献
Xian-Ming Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xian-Ming Chen', 18)}}的其他基金
Intestinal Stem Cell Responses to Cryptosporidium Infection
肠道干细胞对隐孢子虫感染的反应
- 批准号:
10330758 - 财政年份:2020
- 资助金额:
$ 19.63万 - 项目类别:
LncRNA regulation of Type I IFN signaling in intestinal epithelium
LncRNA 对肠上皮 I 型 IFN 信号传导的调节
- 批准号:
10331247 - 财政年份:2020
- 资助金额:
$ 19.63万 - 项目类别:
LincRNAs in Mucosal Defense to AIDS Opportunistic Pathogen Cryptosporidium
LincRNA 在粘膜防御艾滋病机会性病原体隐孢子虫中的作用
- 批准号:
10327943 - 财政年份:2017
- 资助金额:
$ 19.63万 - 项目类别:
LincRNAs in Mucosal Defense to AIDS Opportunistic Pathogen Cryptosporidium
LincRNA 在粘膜防御艾滋病机会病原体隐孢子虫中的作用
- 批准号:
10289715 - 财政年份:2017
- 资助金额:
$ 19.63万 - 项目类别:
Molecular basis of intestinal cryptosporidiosis
肠道隐孢子虫病的分子基础
- 批准号:
10359132 - 财政年份:2015
- 资助金额:
$ 19.63万 - 项目类别:
Molecular basis of intestinal cryptosporidiosis
肠道隐孢子虫病的分子基础
- 批准号:
10324243 - 财政年份:2015
- 资助金额:
$ 19.63万 - 项目类别:
Molecular basis of intestinal cryptosporidiosis
肠道隐孢子虫病的分子基础
- 批准号:
10019152 - 财政年份:2015
- 资助金额:
$ 19.63万 - 项目类别:
Epithelial exosomes and TLR-mediated mucosal defense
上皮外泌体和 TLR 介导的粘膜防御
- 批准号:
8496696 - 财政年份:2011
- 资助金额:
$ 19.63万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 19.63万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 19.63万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 19.63万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 19.63万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 19.63万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 19.63万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 19.63万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 19.63万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 19.63万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 19.63万 - 项目类别: